← Back to headlines




Piper Sandler Cuts Amphastar Pharmaceuticals Price Target Amid Uncertainty
Piper Sandler has cut its price target for Amphastar Pharmaceuticals, Inc. to $21, citing pipeline uncertainty, while also raising the price target for Unity Software.
2 Jun, 13:05 — 2 Jun, 13:05
Sources
Showing 1 of 2 sources
Coverage Timeline
First report: seeking-alpha · 2 Jun, 13:05|Full coverage: 2 · 1h|Window: 1h
Left-leaningCenterRight-leaning
Related Stories

Trump Administration Announces Major Oil Deal to Replenish U.S. Strategic Reserve
29m ago

NATO Warns of Escalating Russian Gray Zone Attacks Across Europe
51m ago

Investors Eye Jobs Data and Major Earnings Reports for Market Direction
1h ago

North Korea Replaces Defense Minister in Military Shake-Up
2h ago